ES2100998T3 - Composiciones farmaceuticas que contienen derivados de triazol para administracion rectal. - Google Patents

Composiciones farmaceuticas que contienen derivados de triazol para administracion rectal.

Info

Publication number
ES2100998T3
ES2100998T3 ES92117609T ES92117609T ES2100998T3 ES 2100998 T3 ES2100998 T3 ES 2100998T3 ES 92117609 T ES92117609 T ES 92117609T ES 92117609 T ES92117609 T ES 92117609T ES 2100998 T3 ES2100998 T3 ES 2100998T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
rectal administration
compositions containing
triazol derivatives
containing triazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117609T
Other languages
English (en)
Inventor
Walter Fries
Gunther Dr Pfaff
Jorg Pfitzner
Gerhard Dr Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MACK CHEM PHARM
Heinrich Mack Nachf GmbH and Co
Original Assignee
MACK CHEM PHARM
Heinrich Mack Nachf GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MACK CHEM PHARM, Heinrich Mack Nachf GmbH and Co filed Critical MACK CHEM PHARM
Application granted granted Critical
Publication of ES2100998T3 publication Critical patent/ES2100998T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A COMPOSCIONES FARMACEUTICAS PARA SU ADMINISTRACION RECTAL QUE CONTIENEN GLICERIDOS SEMI-SINTETICOS PRODUCIDOS MEDIANTE LA INTERESTERIFICACION, Y, COMO INGREDIENTE ACTIVO, DERIVADOS DE LA TRIAZOLA DE LA FORMULA EN LA QUE R1 ES FENIL OPCIONALMENTE SUBSTITUIDO CON ENTRE 1 Y 3 SUBSTITUYENTES INDEPENDIENTEMENTE SELECCIONADOS ENTRE EL GRUPO QUE CONSTA DE F, CL, BR, I, CF3, ALQUIL C1-C4, ALCOXIDO C1-C4, Y 5-CLOROPIRID-2-IL; X ES OH, F, CL O BR; R2 ES H2, CH3 O F; Y R3 ES H O F.
ES92117609T 1991-10-15 1992-10-15 Composiciones farmaceuticas que contienen derivados de triazol para administracion rectal. Expired - Lifetime ES2100998T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4134125A DE4134125C2 (de) 1991-10-15 1991-10-15 Triazol-Derivate enthaltende pharmazeutische Zusammensetzungen zur rektalen Applikation

Publications (1)

Publication Number Publication Date
ES2100998T3 true ES2100998T3 (es) 1997-07-01

Family

ID=6442729

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117609T Expired - Lifetime ES2100998T3 (es) 1991-10-15 1992-10-15 Composiciones farmaceuticas que contienen derivados de triazol para administracion rectal.

Country Status (18)

Country Link
EP (1) EP0537729B1 (es)
JP (1) JPH05294830A (es)
KR (1) KR930007446A (es)
AT (1) ATE150970T1 (es)
CA (1) CA2080566C (es)
DE (2) DE4134125C2 (es)
DK (1) DK0537729T3 (es)
ES (1) ES2100998T3 (es)
FI (1) FI107232B (es)
GR (1) GR3023552T3 (es)
HU (1) HU213202B (es)
IL (1) IL103398A (es)
MX (1) MX9205898A (es)
MY (1) MY108576A (es)
NO (1) NO923992L (es)
NZ (1) NZ244734A (es)
TW (1) TW258661B (es)
ZA (1) ZA927907B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
GR79307B (es) * 1982-06-09 1984-10-22 Pfizer
DE3307217A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte 1,3-diazolyl-2-propanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel

Also Published As

Publication number Publication date
JPH05294830A (ja) 1993-11-09
HUT65417A (en) 1994-06-28
MY108576A (en) 1996-10-31
DE4134125C2 (de) 1995-02-02
CA2080566C (en) 1998-02-17
MX9205898A (es) 1993-05-01
ZA927907B (en) 1993-04-21
NO923992L (no) 1993-04-16
FI107232B (fi) 2001-06-29
NO923992D0 (no) 1992-10-14
DE69218718T2 (de) 1997-08-07
FI924639A0 (fi) 1992-10-14
CA2080566A1 (en) 1993-04-16
IL103398A (en) 1997-08-14
DE4134125A1 (de) 1993-04-22
DE69218718D1 (de) 1997-05-07
GR3023552T3 (en) 1997-08-29
ATE150970T1 (de) 1997-04-15
TW258661B (es) 1995-10-01
EP0537729A1 (en) 1993-04-21
FI924639A (fi) 1993-04-16
HU213202B (en) 1997-03-28
KR930007446A (ko) 1993-05-20
DK0537729T3 (da) 1997-09-22
IL103398A0 (en) 1993-03-15
HU9203236D0 (en) 1992-12-28
EP0537729B1 (en) 1997-04-02
NZ244734A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
ES8300098A1 (es) Procedimiento para preparar compuestos de triazol e imidazol.
SE9002206D0 (sv) New compounds
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
ZA93820B (en) Fungicidal compositions
CA2118937A1 (en) Triazole Antifungal Agents
NZ234410A (en) 3-methoximinopropionic ester derivatives and fungicidal compositions
ATE142421T1 (de) Fungizide zusammensetzung
ES2100998T3 (es) Composiciones farmaceuticas que contienen derivados de triazol para administracion rectal.
GR78881B (es)
ATE30911T1 (de) Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3369512D1 (en) Triazole antifungal agents
DE3781986T2 (de) Substituierte chinoxaline.
ATE74604T1 (de) Substituierte pyrimidochinoxaline.
TH46046EX (th) "สารต้านทานเชื้อราประเภทไตรอาโซล"

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537729

Country of ref document: ES